General Information of the Compound
Compound ID
CP0499506
Compound Name
1-Benzyl-1H-1,3,4b,9-tetraaza-fluorene-2,4-dione
    Show/Hide
Synonyms
1-Benzyl-1H-1,3,4b,9-tetraaza-fluorene-2,4-dione
CHEMBL112256
    Show/Hide
Structure
Formula
C16H12N4O2
Molecular Weight
292.298
Canonical SMILES
O=c1[nH]c(=O)c2c(nc3ccccn23)n1Cc1ccccc1
    Show/Hide
InChI
InChI=1S/C16H12N4O2/c21-15-13-14(17-12-8-4-5-9-19(12)13)20(16(22)18-15)10-11-6-2-1-3-7-11/h1-9H,10H2,(H,18,21,22)
    Show/Hide
InChIKey
JHTRSVKUCQEETB-UHFFFAOYSA-N
Physicochemical Property
logP
1.3858
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
72.16
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 21604934
ChEMBL ID
CHEMBL112256
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01279, Adenosine receptor A3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 370 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-Benzyl-1H-1,3,4b,9-tetraaza-fluorene-2,4-dione )
Drug Name 1-Benzyl-1H-1,3,4b,9-tetraaza-fluorene-2,4-dione
Target(s)
Adenosine A3 receptor (ADORA3)
Inhibitor